查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1855796

2025年人工智慧（AI）赋能的罕见疾病诊断全球市场报告

Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，人工智慧（AI）辅助罕见疾病诊断的市场规模呈指数级增长，预计从2024年的15.4亿美元增长到2025年的19.9亿美元，复合年增长率（CAGR）高达29.1%。这一历史性增长与医疗保健领域人工智慧（AI）的日益普及、罕见疾病研究投入的增加、早期诊断意识的提高、医疗基础设施的不断完善以及政府对数位医疗倡议的大力支持密切相关。

预计未来几年，人工智慧（AI）赋能的罕见疾病诊断市场将呈指数级增长，到2029年市场规模将达到55亿美元，复合年增长率（CAGR）为28.9%。预测期内的成长主要归功于机器学习演算法的广泛应用、个人化医疗需求的不断增长、人工智慧新兴企业与医院合作的日益密切、基因组数据的可用性不断提高以及医疗保健数位化的不断提高。预测期内的关键趋势包括深度学习模型的进步、预测性诊断技术的创新、医学数据自然语言处理的发展、多组体学整合研究以及人工智慧驱动成像技术的持续改进。

自体免疫疾病盛行率的不断上升预计将推动人工智慧驱动的罕见疾病诊断市场扩张。自体免疫疾病是指免疫系统错误地攻击自体健康细胞，导致发炎和组织损伤。越来越多的人出现免疫系统功能障碍，推动了对早期诊断、先进治疗和持续症状管理的需求。人工智慧驱动的罕见疾病诊断能够快速识别复杂疾病，支援个人化治疗方案，并提高诊断准确性，从而帮助管理自体免疫疾病。例如，澳洲健康与福利研究所于2024年6月报告称，到2022年，澳洲约有51.4万人（占总人口的2.0%）将患有类风湿性关节炎，这凸显了对准确诊断和治疗日益增长的需求。因此，自体免疫疾病发生率的上升正在推动人工智慧驱动的罕见疾病诊断市场的成长。

人工智慧驱动的罕见疾病诊断市场中的企业正致力于开发最尖端科技，例如整合基因组诊断解决方案，旨在提高诊断准确性、缩短等待时间并深入了解复杂的遗传疾病。整合基因组诊断解决方案将全基因组定序与人工智慧主导的分析相结合，从而提供全面的遗传资讯。例如，2023年10月，英国生物技术公司牛津奈米孔技术公司（Oxford Nanopore Technologies）和美国人工智慧公司Fabric Genomics宣布推出一项整合全基因组定序解决方案。该合作将快速测序与基于人工智慧的变异解读相结合，从而实现对罕见疾病的快速准确诊断。该系统将即时奈米孔定序与人工智慧驱动的基因组分析相结合，能够快速检测罕见基因突变，为临床医生提供可操作的见解，并提高诊断速度和准确性，尤其是在儿童领域。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税，以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球人工智慧 (AI) 赋能的罕见疾病诊断：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 终端用户产业分析
  • 全球人工智慧（AI）赋能的罕见疾病诊断市场：成长率分析
  • 全球人工智慧（AI）赋能的罕见疾病诊断市场表现：规模与成长，2019-2024年
  • 全球人工智慧（AI）赋能的罕见疾病诊断市场预测：规模与成长，2024-2029年，2034年
  • 全球人工智慧 (AI) 赋能的罕见疾病诊断：潜在市场规模 (TAM)

第六章 市场细分

  • 全球基于人工智慧（AI）的罕见疾病诊断市场：按组件、效能和预测划分，2019-2024年、2024-2029年、2034年
  • 软体
  • 硬体
  • 服务
  • 全球基于人工智慧（AI）的罕见疾病诊断市场：按技术、性能和预测划分，2019-2024年、2024-2029年、2034年
  • 机器学习
  • 深度学习
  • 自然语言处理
  • 电脑视觉
  • 其他技术
  • 全球人工智慧（AI）赋能的罕见疾病诊断市场：按部署模式、效能和预测划分，2019-2024年、2024-2029年、2034年
  • 云端基础的
  • 本地部署
  • 全球基于人工智慧（AI）的罕见疾病诊断市场：按诊断类型、效能和预测划分，2019-2024年、2024-2029年、2034年
  • 遗传性疾病
  • 自体免疫疾病
  • 代谢紊乱
  • 感染疾病
  • 其他诊断类型
  • 全球基于人工智慧（AI）的罕见疾病诊断市场（按最终用户、效能和预测划分，2019-2024年、2024-2029年、2034年）
  • 医院
  • 诊断中心
  • 研究所
  • 专科诊所
  • 其他最终用户
  • 全球基于人工智慧（AI）的罕见疾病诊断市场：按软体、类型、效能和预测进行细分，2019-2024年、2024-2029年、2034年
  • 临床决策支持
  • 数据分析平台
  • 基因组分析工具
  • 机器学习演算法
  • 诊断报告软体
  • 全球基于人工智慧（AI）的罕见疾病诊断市场：按硬体、类型、效能和预测进行细分，2019-2024年、2024-2029年、2034年
  • 定序设备
  • 影像设备
  • 实验室设备
  • 计算伺服器
  • 诊断感测器
  • 全球基于人工智慧（AI）的罕见疾病诊断市场：按服务、类型、效能和预测细分，2019-2024年、2024-2029年、2034年
  • 咨询服务
  • 实施与集成
  • 培训和支持
  • 资料管理服务
  • 维护和升级

第七章 区域和国家分析

  • 全球基于人工智慧（AI）的罕见疾病诊断市场：按地区、绩效和预测划分，2019-2024年、2024-2029年、2034年
  • 全球基于人工智慧（AI）的罕见疾病诊断市场：国家/地区、绩效及预测，2019-2024年、2024-2029年、2034年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第二十章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第三十章：竞争格局与公司概况

  • 人工智慧（AI）赋能的罕见疾病诊断市场：竞争格局
  • 人工智慧（AI）赋能的罕见疾病诊断市场：公司概况
    • Ambry Genetics Corporation Overview, Products and Services, Strategy and Financial Analysis
    • MedGenome Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Sophia Genetics SA Overview, Products and Services, Strategy and Financial Analysis
    • Variantyx Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Facial Dysmorphology Novel Analysis Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Atropos Health Inc.
  • Congenica Ltd.
  • Saventic Care Sp. z oo
  • Rapid Innovation LLC
  • Centogene NV
  • Impilo AB
  • ThinkGenetic Inc.
  • ClairLabs Ltd.
  • 3billion Inc.
  • OpenEvidence Inc.
  • GenomeUp SRL
  • Mendel.ai Inc.
  • RareSum GmbH
  • DeepRare AI Solutions
  • Zebra-Llama Project

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章：高潜力市场国家、细分市场与策略

  • 2029年人工智慧（AI）赋能的罕见疾病诊断市场：提供新机会的国家
  • 2029年人工智慧（AI）赋能的罕见疾病诊断市场：蕴藏新机会的细分领域
  • 2029年人工智慧（AI）赋能的罕见疾病诊断市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章附录

简介目录
Product Code: r38445

Artificial intelligence (AI)-powered rare disease diagnosis involves the application of advanced algorithms and machine learning techniques to accurately identify uncommon medical conditions. These systems process complex patient data, including genetic, clinical, and imaging information, to uncover patterns that may be overlooked by traditional diagnostic approaches.

The primary components of artificial intelligence (AI)-powered rare disease diagnosis include software, hardware, and services. Software comprises programs, data, and instructions that guide a computer or device in performing specific tasks. Technologies involved include machine learning, deep learning, natural language processing, computer vision, and others. Deployment modes consist of cloud-based and on-premises solutions. Diagnosis types cover genetic disorders, autoimmune disorders, metabolic disorders, infectious diseases, and more, with end users including hospitals, diagnostic centers, research institutes, specialty clinics, and other healthcare organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The artificial intelligence (AI)-powered rare disease diagnosis market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI)-powered rare disease diagnosis market statistics, including the artificial intelligence (AI)-powered rare disease diagnosis industry global market size, regional shares, competitors with the artificial intelligence (AI)-powered rare disease diagnosis market share, detailed artificial intelligence (AI)-powered rare disease diagnosis market segments, market trends, and opportunities, and any further data you may need to thrive in the artificial intelligence (AI)-powered rare disease diagnosis industry. This artificial intelligence (AI)-powered rare disease diagnosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The artificial intelligence (AI)-powered rare disease diagnosis market size has grown exponentially in recent years. It will grow from $1.54 billion in 2024 to $1.99 billion in 2025 at a compound annual growth rate (CAGR) of 29.1%. The growth observed during the historic period can be linked to increasing adoption of artificial intelligence (AI) in healthcare, higher investment in rare disease research, greater awareness of early diagnosis, expansion of healthcare infrastructure, and stronger government support for digital health initiatives.

The artificial intelligence (AI)-powered rare disease diagnosis market size is expected to see exponential growth in the next few years. It will grow to $5.50 billion in 2029 at a compound annual growth rate (CAGR) of 28.9%. The growth projected for the forecast period can be attributed to wider integration of machine learning algorithms, rising demand for personalized medicine, growing collaborations between AI startups and hospitals, increased availability of genomic data, and ongoing digitalization of healthcare. Key trends during the forecast period include advancements in deep learning models, innovations in predictive diagnostics, developments in natural language processing for medical data, research in multi-omics integration, and continuous enhancements in AI-driven imaging technologies.

The growing prevalence of autoimmune disorders is expected to drive the expansion of the AI-powered rare disease diagnosis market. Autoimmune disorders occur when the immune system mistakenly attacks the body's healthy cells, resulting in inflammation and tissue damage. The rising number of individuals experiencing immune system dysfunctions has led to a higher demand for early diagnosis, advanced treatments, and continuous symptom management. AI-powered rare disease diagnosis helps manage autoimmune conditions by quickly identifying complex diseases, supporting personalized treatment plans, and improving diagnostic accuracy. For example, the Australian Institute of Health and Welfare reported in June 2024 that approximately 514,000 people (2.0%) in Australia were living with rheumatoid arthritis in 2022, highlighting the growing need for accurate diagnosis and treatment. As such, the increasing incidence of autoimmune disorders is driving market growth in AI-powered rare disease diagnosis.

Companies in the AI-powered rare disease diagnosis market are focusing on developing cutting-edge technologies such as unified genomic diagnostic solutions to improve diagnostic precision, reduce waiting times, and offer deeper insights into complex genetic conditions. A unified genomic diagnostics solution integrates whole-genome sequencing with AI-driven analysis to provide comprehensive genetic insights. For example, in October 2023, Oxford Nanopore Technologies, a UK-based biotechnology firm, and Fabric Genomics, a US-based AI-driven company, launched a unified whole-genome sequencing solution. This collaboration combines rapid sequencing with AI-based variant interpretation, enabling faster and more accurate diagnosis of rare diseases. The system integrates real-time nanopore sequencing with AI-powered genomic analysis to quickly detect rare genetic variants, offering clinicians actionable insights that enhance diagnostic speed and accuracy, especially in pediatric care.

In May 2022, Sema4, a US-based AI-driven genomic and clinical data intelligence platform, acquired GeneDx Holdings Corp. in a bid to strengthen its position in rare disease diagnostics. The acquisition, which was made for an undisclosed amount, allows Sema4 to merge GeneDx's vast genomic data resources with its AI-powered platforms. This integration is aimed at improving diagnostic precision and accelerating personalized medicine. GeneDx Holdings, a US-based biotechnology and medical diagnostics company, specializes in using genomics and artificial intelligence to diagnose rare genetic diseases.

Major players in the artificial intelligence (AI)-powered rare disease diagnosis market are Ambry Genetics Corporation, MedGenome Inc., Sophia Genetics SA, Variantyx Inc., Facial Dysmorphology Novel Analysis, Atropos Health Inc., Congenica Ltd., Saventic Care Sp. z o.o., Rapid Innovation LLC, Centogene N.V., Impilo AB, ThinkGenetic Inc., ClairLabs Ltd., 3billion Inc., OpenEvidence Inc., GenomeUp S.R.L., Mendel.ai Inc., RareSum GmbH, DeepRare AI Solutions, Zebra-Llama Project.

North America was the largest region in the artificial intelligence (AI)-powered rare disease diagnosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in artificial intelligence (AI)-powered rare disease diagnosis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the artificial intelligence (AI)-powered rare disease diagnosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence (AI)-powered rare disease diagnosis market includes revenues earned by entities by providing services such as genomic sequencing analysis, clinical data integration, artificial intelligence (AI)-based imaging interpretation, predictive analytics for rare diseases, and personalized treatment recommendations. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI)-powered rare disease diagnosis market also includes sales of genetic testing kits, imaging scanners, biosensors, lab automation instruments, point-of-care testing devices, wearable health monitors, sequencing machines, microfluidic chips, and pathology slide scanners. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence (ai)-powered rare disease diagnosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence (ai)-powered rare disease diagnosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai)-powered rare disease diagnosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Component: Software; Hardware; Services
  • 2) By Technology: Machine Learning; Deep Learning; Natural Language Processing; Computer Vision; Other Technologies
  • 3) By Deployment Mode: Cloud-Based; On-Premises
  • 4) By Diagnosis Type: Genetic Disorders; Autoimmune Disorders; Metabolic Disorders; Infectious Diseases; Other Diagnosis Types
  • 5) By End-User: Hospitals; Diagnostic Centers; Research Institutes; Specialty Clinics; Other End-Users
  • Subsegments:
  • 1) By Software: Clinical Decision Support; Data Analytics Platforms; Genomic Interpretation Tools; Machine Learning Algorithms; Diagnostic Reporting Software
  • 2) By Hardware: Sequencing Instruments; Imaging Devices; Laboratory Equipment; Computational Servers; Diagnostic Sensors
  • 3) By Services: Consulting Services; Implementation And Integration; Training And Support; Data Management Services; Maintenance And Upgrades
  • Companies Mentioned: Ambry Genetics Corporation; MedGenome Inc.; Sophia Genetics SA; Variantyx Inc.; Facial Dysmorphology Novel Analysis; Atropos Health Inc.; Congenica Ltd.; Saventic Care Sp. z o.o.; Rapid Innovation LLC; Centogene N.V.; Impilo AB; ThinkGenetic Inc.; ClairLabs Ltd.; 3billion Inc.; OpenEvidence Inc.; GenomeUp S.R.L.; Mendel.ai Inc.; RareSum GmbH; DeepRare AI Solutions; Zebra-Llama Project
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Characteristics

3. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Trends And Strategies

4. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Growth Rate Analysis
  • 5.4. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Total Addressable Market (TAM)

6. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Segmentation

  • 6.1. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Software
  • Hardware
  • Services
  • 6.2. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Machine Learning
  • Deep Learning
  • Natural Language Processing
  • Computer Vision
  • Other Technologies
  • 6.3. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cloud-Based
  • On-Premises
  • 6.4. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Genetic Disorders
  • Autoimmune Disorders
  • Metabolic Disorders
  • Infectious Diseases
  • Other Diagnosis Types
  • 6.5. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic Centers
  • Research Institutes
  • Specialty Clinics
  • Other End-Users
  • 6.6. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clinical Decision Support
  • Data Analytics Platforms
  • Genomic Interpretation Tools
  • Machine Learning Algorithms
  • Diagnostic Reporting Software
  • 6.7. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sequencing Instruments
  • Imaging Devices
  • Laboratory Equipment
  • Computational Servers
  • Diagnostic Sensors
  • 6.8. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Consulting Services
  • Implementation And Integration
  • Training And Support
  • Data Management Services
  • Maintenance And Upgrades

7. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Regional And Country Analysis

  • 7.1. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 8.1. Asia-Pacific Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 9.1. China Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview
  • 9.2. China Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 10.1. India Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 11.1. Japan Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview
  • 11.2. Japan Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 12.1. Australia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 13.1. Indonesia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 14.1. South Korea Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview
  • 14.2. South Korea Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 15.1. Western Europe Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview
  • 15.2. Western Europe Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 16.1. UK Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 17.1. Germany Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 18.1. France Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 19.1. Italy Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 20.1. Spain Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 21.1. Eastern Europe Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview
  • 21.2. Eastern Europe Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 22.1. Russia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 23.1. North America Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview
  • 23.2. North America Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 24.1. USA Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview
  • 24.2. USA Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 25.1. Canada Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview
  • 25.2. Canada Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 26.1. South America Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview
  • 26.2. South America Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 27.1. Brazil Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 28.1. Middle East Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview
  • 28.2. Middle East Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

  • 29.1. Africa Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Overview
  • 29.2. Africa Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Competitive Landscape And Company Profiles

  • 30.1. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Competitive Landscape
  • 30.2. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Company Profiles
    • 30.2.1. Ambry Genetics Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. MedGenome Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Sophia Genetics SA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Variantyx Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Facial Dysmorphology Novel Analysis Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Other Major And Innovative Companies

  • 31.1. Atropos Health Inc.
  • 31.2. Congenica Ltd.
  • 31.3. Saventic Care Sp. z o.o.
  • 31.4. Rapid Innovation LLC
  • 31.5. Centogene N.V.
  • 31.6. Impilo AB
  • 31.7. ThinkGenetic Inc.
  • 31.8. ClairLabs Ltd.
  • 31.9. 3billion Inc.
  • 31.10. OpenEvidence Inc.
  • 31.11. GenomeUp S.R.L.
  • 31.12. Mendel.ai Inc.
  • 31.13. RareSum GmbH
  • 31.14. DeepRare AI Solutions
  • 31.15. Zebra-Llama Project

32. Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

34. Recent Developments In The Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market

35. Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market High Potential Countries, Segments and Strategies

  • 35.1 Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer